Heidi Overton is Trump’s pick for next FDA commissioner. Here’s what to know.

By Alexander Gaffney, MS, RAC and Ned Pagliarulo

President Donald Trump plans to nominate White House policy aide Heidi Overton as the next FDA commissioner, putting a figure closely involved in the administration’s health policy agenda in line to lead the agency.

Beyond the nomination itself, her selection raises bigger questions about FDA’s regulatory direction, leadership and the future of initiatives already underway across the agency.

This AgencyIQ analysis examines Overton’s policy background and regulatory philosophy, the dynamics surrounding her potential confirmation and the key signals regulated industries should watch as FDA prepares for another leadership transition.

Fill out the form to read the full analysis.